Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
08/2006
08/16/2006CN1269531C Light-stabilized in vivo stain composition and method of manufacture
08/10/2006WO2006082495A1 Peroxisome proliferator activated receptor modulators
08/09/2006EP1687638A2 Analysis of mass spectral data in the quiet zones
08/09/2006EP1687286A1 Developments in biologically active methylene blue derivatives (2)
08/08/2006US7087416 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
08/03/2006WO2006079720A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
08/03/2006CA2595975A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
08/02/2006EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/02/2006EP0970935B1 Method of separating optical isomers
08/01/2006US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders
08/01/2006US7084137 Treating glues, sizes, paper and board, textiles, leather, wood, wooden materials, paints, synthetic articles, cooling lubricants with a thiazine microbiocides; chemical synthesis from isothiocyanate; used as fungicides, batericides, miticides, insecticides, nematocides
08/01/2006US7083884 Organophotoreceptor with charge transport material having a hydrazone group linked to an epoxy group and a heterocyclic ring
07/2006
07/27/2006US20060167315 N-(aminosulfonylalkylene)-N'-(phenyl-or pyridyl)phthalamide derivatives, e.g., N2-(2-ethylsulfamoyl-1-methylethyl)-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide; is effective even at low dosage
07/27/2006US20060167248 Substituted morpholine and thiomorpholine derivatives
07/27/2006US20060166841 Process for the preparation of phenothiazine granules having improved properties
07/27/2006US20060166038 N,N'-bis(10-(p-(2-ethylhexoxy-)phenyl)-)-3,3'-diphenoxazine; charge transfer compounds; oxazine dyes; thin films/electrical/; improved efficiency and color purity; electroluminescence; used in dry and wet processes; driving characteristics; highcharge/hole transport capability
07/26/2006CN1266155C 6-chloro-4-hydroxy-2-methyl-2H-thieno-(2,3-e)-1,2-thiazine-1,1-dioxide-3
07/20/2006WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
07/20/2006US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
07/19/2006EP1680409A2 Ph sensitive prodrugs of 2,6-diisopropylphenol
07/13/2006WO2006032879A3 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
07/13/2006US20060154922 Muscarinic agonists
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/12/2006EP1678128A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
07/11/2006US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor
07/11/2006CA2364718C Monoamine reuptake inhibitors for treatment of cns disorders
07/06/2006US20060148793 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
07/04/2006US7071211 Vision disorders; adjustment activation of gelatinase
07/04/2006CA2250840C Antivirally active heterocyclic azahexane derivatives
06/2006
06/29/2006US20060142277 Substituted aralkyl derivatives
06/29/2006US20060142264 Novel amide derivatives
06/27/2006US7067532 Substituted quinolines as antitumor agents
06/27/2006CA2138740C Mixtures of alkylated aromatic amines and phenothiazines
06/21/2006CN1791585A Cyclic sulfonamides for inhibition of gamma-secretase.
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
06/15/2006WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
06/14/2006EP1667947A1 Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds
06/14/2006CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
06/13/2006US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma
06/13/2006US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders
06/08/2006WO2003077857A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
06/08/2006US20060122061 Arylphenyl-substituted cyclic ketoenols
06/08/2006US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells
06/08/2006DE102004057086A1 Phenothiazine, -S-oxide und S,S-dioxide sowie Phenoxazine als Emitter für OLED Phenothiazines, -S-oxide and S, S-dioxide and phenoxazines as emitter for OLED
06/08/2006DE102004057073A1 Verwendung von Phenothiazin-S-oxiden und -S,S-dioxiden als Matrixmaterialien für organische Leuchtdioden Use of phenothiazine S-oxides and S, S-dioxides as matrix materials for organic light-
06/07/2006EP1666469A1 Plasminogen activator inhibitor-1 inhibitor
06/07/2006EP1664088A2 Hemiasterlin derivatives and uses thereof
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
06/06/2006US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria
06/06/2006CA2362632C R-substituted-2- or 3-aminomethyl-4-amino-3,4-dihydro-2h-1,4-benzoxazines as intermediates for producing analgesic agents
06/01/2006WO2006057460A1 Nitrogen-containing fused ring compound and use thereof
06/01/2006US20060116368 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor
06/01/2006US20060115516 Copolymerizable methine and anthraquinone compounds and articles containing them
06/01/2006CA2588528A1 Copolymerizable methine and anthraquinone compounds and articles containing them
05/2006
05/31/2006EP1661572A1 Novel use of cannabinoid receptor agonist
05/30/2006US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect
05/30/2006US7053085 EP4 receptor agonist, compositions and methods thereof
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1659117A1 2-naphthylimino-1,3-thiazine derivative
05/24/2006DE102004054847A1 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
05/23/2006US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity
05/18/2006WO2006050830A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same
05/18/2006WO2005110422A3 Treatment of diseases associated with altered level of amyloid beta peptides
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/17/2006CN1774427A Transient optical state change materials useful in copy-protected compact discs
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/16/2006CA2195724C Process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
05/11/2006CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors
05/10/2006CN1255390C Preparation of 2-cyanophenthiazine
05/04/2006WO2006047503A2 Inhibitors of c-fms kinase
05/04/2006WO2006047479A2 C-fms kinase inhibitors
05/03/2006EP1651643A2 Bicyclic compounds and compositions as pdf inhibitors
05/03/2006EP1299366B1 Method for producing a phenothiazine granulate with improved properties
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
04/2006
04/27/2006WO2005123706A9 Crystalline polymorphs of (3s)-n-hydroxy-4({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide
04/27/2006WO2005054871A3 Analysis of mass spectral data in the quiet zones
04/27/2006US20060089352 Substituted thiazines as material protecting agents
04/26/2006CN1764659A Prostaglandin analogs as EP4 receptor antagonists
04/26/2006CN1762965A A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor
04/26/2006CN1253442C Novel thiazine or pyrazine derivatives
04/20/2006WO2006042097A1 Method for producing phenothiazinium compounds
04/20/2006WO2005113524A8 Fluorescent method and compounds to monitor protein-lipid binding
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/19/2006EP1647543A1 A method for inhibiting polymerization of (Meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor
04/19/2006EP1212330B1 Androgen receptor modulator compounds and methods
04/19/2006CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
04/19/2006CN1252055C Biphenyl carboxamides compounds
04/18/2006US7030238 C-nitroso compounds and use thereof
04/13/2006WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
04/13/2006US20060079682 Method for producing phenothiazinium compounds
04/13/2006US20060079681 Process for exchanging anions in phenothiazinium derivatives
04/12/2006EP1644346A1 Cyclic sulfonamides for inhibition of gamma-secretase
04/11/2006US7026475 carbapenem derivatives with an antibacterial activity
04/05/2006EP1173427B1 Hydroxamic acid derivative
03/2006
03/30/2006WO2006032847A1 Wound healing
03/30/2006US20060069253 Aryl-substituted heterocyclic enaminones
03/30/2006CA2579169A1 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
03/29/2006EP1638951A1 Cyclohexyl sulphones as gamma-secretase inhibitors
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 52